Tazemetostat

Tazemetostat is a methyltransferase inhibitor used to treat metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Tazemetostatum, [1, 1′-Biphenyl]-3-carboxamide, N-[(1, 2-dihydro-4 and 6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4′-(4-morpholinylmethyl)-. Its PubChem CID is 66558664.

CAS No 1403254-99-8
Molecular Formula C34H44N4O4
Molecular Weight 572.7 g/mol
Synonyms N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide

Frequently Asked Questions